- R&D
With its squishy synthetic platelets, the startup SelSym seeks to reduce risk from bleeding
Platelets are always in low supply with an additional problem with these sticky cell pieces being that platelets usually need to be utilized within...No Proof of Brain Injury in ‘Havana Syndrome’ Patients
A comprehensive series of sophisticated examinations conducted by researchers revealed the absence of brain injuries or degenerative conditions among U.S. diplomats and governmental staff...Semaglutide Shows Promise in Treating Liver Fat in HIV Patients
In a recent unveiling at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), a study illuminated the potential of semaglutide, a medication frequently...Prolonged Epigenetic Suppression in Mice Strengthens Argument for Therapeutic Applications
Recent mouse study findings suggest that epigenetic gene silencing could effectively hinder a target gene for a substantial duration, potentially nearing a...
- Clinical
Neumora Schizophrenia Therapy on Hold After Rabbits Face Convulsions
The FDA has halted a phase 1 trial of Neumora Therapeutics’ treatment for schizophrenia after preclinical investigations uncovered instances of convulsions in rabbits who...Cerevel Reports Phase 3 Parkinson’s Success
Within the context of AbbVie's $8.7 billion acquisition of Cerevel Therapeutics is now enjoying its turn in the limelight. Avapadon was brought to the...MaaT Touts 18-Month Data as Proof of Microbiome Therapy Viability
Microbiome biotech MaaT Pharma says it will market its pooled fecal treatment medicine for acute graft-versus-host disease (aGvHD) in two years based on data...Zeposia medication from Bristol Myers Squibb falls short in a study for Crohn’s disease
As a therapy for two uncommon illnesses, ulcerative colitis (UC) and multiple sclerosis (MS), Bristol Myers Squibb's Zeposia (ozanimod) has garnered interest. However, the...
- Manufacturing
Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...Rovi’s Expansion in Pharmaceutical Production with Moderna
The Laboratorios Farmacéuticos Rovi and Moderna partnership has recently achieved a milestone with the establishment of a new production facility aimed at...Bristol Myers Squibb Expands Irish Campus with $400M Investment in Drug Manufacturing
Bristol Myers Squibb (BMS) has disclosed a significant infusion of $400 million into its Cruiserath Campus located in Dublin 15, also recognized...Trial for Gritstone’s BARDA-funded COVID-19 vaccine delayed due to production issues
Gritstone Bio has secured a substantial sum of $433 million in federal funding earmarked for the testing of its cutting-edge COVID-19 vaccine....
- Commercial
Highridge Medical: ZimVie’s successful spinout of its spine division
The successful sale of ZimVie's spine division to investment firm H.I.G. Capital has triggered many noteworthy developments in the medical space that have resulted...Olympus Joins Hands With American Lung Association For Cancer Education
Olympus has joined forces with the American Lung Association (ALA) to raise awareness about the detection and staging of lung nodules, supporting educational materials...Johnson Matthey Sells Medical Metal Unit to Montagu in $700M Deal
Johnson Matthey, a British corporation specializing in metals and chemicals, is preparing to divest its global Medical Device Components (MDC) division, which encompasses manufacturing...
- Technology
Microscopic “super bots” repair neural wound model
In a recent development, scientists have brought science fiction to life by creating miniature biological robots, known as biobots, capable of healing...Amgen Expands Amazon Partnership to Seek Generative AI Solutions
In a concerted effort to enhance the discovery and manufacturing processes of pharmaceuticals, Amgen is broadening its longstanding alliance with the technology...Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...
- Regulatory
The FDA cautions against adverse reactions linked to counterfeit Botox injections
The CDC and the FDA US began a joint investigation to stop the distribution of counterfeit Botox which have caused about 19 adverse reactions...FDA puts Neumora’s schizophrenia medication on hold because of rabbit convulsions
The FDA has placed Neumora's schizophrenia medication on hold due to reports of convulsions in rabbits. Neumora Therapeutics' phase 1 study aimed at treating...Eisai and Biogen’s injectable Alzehimer drug faces setback from the FDA
First, due to the burden on its patients and healthcare infrastructure, and now with the Food and Drug Administration's (FDA) demand that they submit...Regeneron to conduct confirmatory trials for odronextamab for FDA approval
Mohsin Riaz - 0With Regeneron’s desire to move its blood cancer medicine odronextamab from fifth line to first in some instances as treatment, the Food and Drug...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
With its squishy synthetic platelets, the startup SelSym seeks to reduce risk from bleeding
Platelets are always in low supply with an additional problem with these sticky cell pieces being that platelets usually need to be utilized within...No Proof of Brain Injury in ‘Havana Syndrome’ Patients
A comprehensive series of sophisticated examinations conducted by researchers revealed the absence of brain injuries or degenerative conditions among U.S. diplomats and governmental staff...Semaglutide Shows Promise in Treating Liver Fat in HIV Patients
In a recent unveiling at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), a study illuminated the potential of semaglutide, a medication frequently...Prolonged Epigenetic Suppression in Mice Strengthens Argument for Therapeutic Applications
Recent mouse study findings suggest that epigenetic gene silencing could effectively hinder a target gene for a substantial duration, potentially nearing a...
- Clinical
Neumora Schizophrenia Therapy on Hold After Rabbits Face Convulsions
The FDA has halted a phase 1 trial of Neumora Therapeutics’ treatment for schizophrenia after preclinical investigations uncovered instances of convulsions in rabbits who...Cerevel Reports Phase 3 Parkinson’s Success
Within the context of AbbVie's $8.7 billion acquisition of Cerevel Therapeutics is now enjoying its turn in the limelight. Avapadon was brought to the...MaaT Touts 18-Month Data as Proof of Microbiome Therapy Viability
Microbiome biotech MaaT Pharma says it will market its pooled fecal treatment medicine for acute graft-versus-host disease (aGvHD) in two years based on data...Zeposia medication from Bristol Myers Squibb falls short in a study for Crohn’s disease
As a therapy for two uncommon illnesses, ulcerative colitis (UC) and multiple sclerosis (MS), Bristol Myers Squibb's Zeposia (ozanimod) has garnered interest. However, the...
- Manufacturing
Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...Rovi’s Expansion in Pharmaceutical Production with Moderna
The Laboratorios Farmacéuticos Rovi and Moderna partnership has recently achieved a milestone with the establishment of a new production facility aimed at...Bristol Myers Squibb Expands Irish Campus with $400M Investment in Drug Manufacturing
Bristol Myers Squibb (BMS) has disclosed a significant infusion of $400 million into its Cruiserath Campus located in Dublin 15, also recognized...Trial for Gritstone’s BARDA-funded COVID-19 vaccine delayed due to production issues
Gritstone Bio has secured a substantial sum of $433 million in federal funding earmarked for the testing of its cutting-edge COVID-19 vaccine....
- Commercial
Highridge Medical: ZimVie’s successful spinout of its spine division
The successful sale of ZimVie's spine division to investment firm H.I.G. Capital has triggered many noteworthy developments in the medical space that have resulted...Olympus Joins Hands With American Lung Association For Cancer Education
Olympus has joined forces with the American Lung Association (ALA) to raise awareness about the detection and staging of lung nodules, supporting educational materials...Johnson Matthey Sells Medical Metal Unit to Montagu in $700M Deal
Johnson Matthey, a British corporation specializing in metals and chemicals, is preparing to divest its global Medical Device Components (MDC) division, which encompasses manufacturing...
- Technology
Microscopic “super bots” repair neural wound model
In a recent development, scientists have brought science fiction to life by creating miniature biological robots, known as biobots, capable of healing...Amgen Expands Amazon Partnership to Seek Generative AI Solutions
In a concerted effort to enhance the discovery and manufacturing processes of pharmaceuticals, Amgen is broadening its longstanding alliance with the technology...Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...
- Regulatory
The FDA cautions against adverse reactions linked to counterfeit Botox injections
The CDC and the FDA US began a joint investigation to stop the distribution of counterfeit Botox which have caused about 19 adverse reactions...FDA puts Neumora’s schizophrenia medication on hold because of rabbit convulsions
The FDA has placed Neumora's schizophrenia medication on hold due to reports of convulsions in rabbits. Neumora Therapeutics' phase 1 study aimed at treating...Eisai and Biogen’s injectable Alzehimer drug faces setback from the FDA
First, due to the burden on its patients and healthcare infrastructure, and now with the Food and Drug Administration's (FDA) demand that they submit...Regeneron to conduct confirmatory trials for odronextamab for FDA approval
Mohsin Riaz - 0With Regeneron’s desire to move its blood cancer medicine odronextamab from fifth line to first in some instances as treatment, the Food and Drug...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Phase 3 trial data for Astellas’s GA drug yielded positive results
A mere six weeks after obtaining FDA approval, Astellas Pharma is already...
FDA Gives Green Light to GSK’s Innovative Bone Cancer Drug, Validating Billion-Dollar Investment
The Food and Drug Administration (FDA) has granted approval for GSK's groundbreaking...
Coherus to move beyond biosimilars with a cancer immunotherapy drug
Coherus Biosciences, known for developing biosimilars, had decided to extend its objectives...
Must Read
Neumora Schizophrenia Therapy on Hold After Rabbits Face Convulsions
The FDA has halted a phase 1 trial of Neumora Therapeutics’ treatment for schizophrenia...
Cerevel Reports Phase 3 Parkinson’s Success
Within the context of AbbVie's $8.7 billion acquisition of Cerevel Therapeutics is now enjoying...
The FDA cautions against adverse reactions linked to counterfeit Botox injections
The CDC and the FDA US began a joint investigation to stop the distribution...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com